VCP and amyotrophic lateral sclerosis: VCP mutations are predominantly located within the N-terminal ubiquitin-binding domain (69.2%, 18/26), indicating that the malfunction of poly-ubiquitinated protein degradation may be the major pathogenesis of ALS (2).